José Manuel Feliciano Guzmán

Mx. José Manuel Feliciano Guzmán

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Microbial Drug Resistance
Verified
Journal Article
Closed access
Luis Esaú López-JácomeLuis Esaú López-Jácome
Luis Esaú López-Jácome
DFDiana Fernández-Rodríguez
Diana Fernández-Rodríguez
RFRafael Franco-Cendejas
Rafael Franco-Cendejas
ACAdrián Camacho-Ortiz
Adrián Camacho-Ortiz
RMRayo Morfin-Otero
Rayo Morfin-Otero
Elvira Garza-GonzálezElvira Garza-González
Elvira Garza-González
Aim: This study aims to assess the changes in antimicrobial resistance among some critical and high-priority microorganisms collected previously and during the coronavirus disease 2019 (COVID-19) pandemic in Mexico. Methods: We collected antimicrobial susceptibility data for critical and high-priority microorganisms from blood, urine, respiratory samples, and from all specimens, in which the pathogen may be considered a causative agent. Data were stratified and compared for two periods: 2019 versus 2020 and second semester 2019 (prepandemic) versus the second semester 2020 (pandemic). Results: In the analysis of second semester 2019 versus the second semester 2020, in blood samples, increased resistance to oxacillin (15.2% vs. 36.9%), erythromycin (25.7% vs. 42.8%), and clindamycin (24.8% vs. 43.3%) ( p ≤ 0.01) was detected for Staphylococcus aureus , to imipenem (13% vs. 23.4%) and meropenem (11.2% vs. 21.4) ( p ≤ 0.01), for Klebsiella pneumoniae . In all specimens, increased ampicillin and tetracycline resistance was detected for Enterococcus faecium ( p ≤ 0.01). In cefepime, meropenem, levofloxacin, and gentamicin ( p ≤ 0.01), resistance was detected for Escherichia coli ; and in piperacillin-tazobactam, cefepime, imipenem, meropenem, ciprofloxacin, levofloxacin, and gentamicin ( p ≤ 0.01), resistance was detected for Pseudomonas aeruginosa . Conclusion: Antimicrobial resistance increased in Mexico during the COVID-19 pandemic. The increase in oxacillin resistance for S. aureus and carbapenem resistance for K. pneumoniae recovered from blood specimens deserves special attention. In addition, an increase in erythromycin resistance in S. aureus was detected, which may be associated with high azithromycin use. In general, for Acinetobacter baumannii and P. aeruginosa , increasing resistance rates were detected.

7 September 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
Fabian Rojas-LariosFabian Rojas-Larios
Fabian Rojas-Larios
Bernardo Alfonso Martinez-GuerraBernardo Alfonso Martinez-Guerra
Bernardo Alfonso Martinez-Guerra
Luis Esaú López-JácomeLuis Esaú López-Jácome
Luis Esaú López-Jácome
EBEnrique Bolado-Martínez
Enrique Bolado-Martínez
MVMaría del Rosario Vázquez-Larios
María del Rosario Vázquez-Larios
Elvira Garza-GonzálezElvira Garza-González
Elvira Garza-González
We analyzed the antimicrobial resistance (AMR) data of 6519 clinical isolates of Escherichia coli (n = 3985), Klebsiella pneumoniae (n = 775), Acinetobacter baumannii (n = 163), Pseudomonas aeruginosa (n = 781), Enterococcus faecium (n = 124), and Staphylococcus aureus (n = 691) from 43 centers in Mexico. AMR assays were performed using commercial microdilution systems (37/43) and the disk diffusion susceptibility method (6/43). The presence of carbapenemase-encoding genes was assessed using PCR. Data from centers regarding site of care, patient age, and clinical specimen were collected. According to the site of care, the highest AMR was observed in E. coli, K. pneumoniae, and P. aeruginosa isolates from ICU patients. In contrast, in A. baumannii, higher AMR was observed in isolates from hospitalized non-ICU patients. According to age group, the highest AMR was observed in the ≥60 years age group for E. coli, E. faecium, and S. aureus, and in the 19–59 years age group for A. baumannii and P. aeruginosa. According to clinical specimen type, a higher AMR was observed in E. coli, K. pneumoniae, and P. aeruginosa isolates from blood specimens. The most frequently detected carbapenemase-encoding gene in E. coli was blaNDM (84%).

1 January 2023 in Abanico Veterinario
Verified
Journal Article
Open access
PDF file
MHMayra Hernández-Hernández
Mayra Hernández-Hernández
LGLuis García-Márquez
Luis García-Márquez
JGJavier Gutiérrez-Jiménez
Javier Gutiérrez-Jiménez
JGJosé Manuel Feliciano Guzmán
José Manuel Feliciano Guzmán
RLRaúl López-Santiz
Raúl López-Santiz
GERARDO URIEL BAUTISTA TRUJILLOGERARDO URIEL BAUTISTA TRUJILLO
GERARDO URIEL BAUTISTA TRUJILLO
Positive cases of Streptococcus in tilapia cause serious economic losses, however, there are no reports on the prevalence of Streptococcus in tilapia farmed within ponds and cages in the tropics, this is the first report about it. The goal was to compare the prevalence of beta-haemolytic streptococci in tilapia (Oreochromis niloticus) from pond and cage culture farming, in Chiapas, Mexico, also, evaluate the susceptibility to antibiotics. 155 fish between 250-300 gr were collected in 31 farms (12 ponds and 19 cages). The highest prevalence (45.16%, P<0.05) of beta-haemolytic streptococci was in fish with clinical manifestations from cages, compared to fish from ponds. S. agalactiae and S. alactolyticus were identified. Signs in fish infected with Streptococcus agalactiae included exophthalmia, ascites, cerebral congestion, hemorrhages, and melanization. 100% of the S. agalactiae strains were susceptible to beta-lactams, clindamycins, among others. There is a higher prevalence of beta-haemolytic streptococci in fish farming in cages compared to pond culture. The information generated in this study favors the implementation of sanitary strategies to optimize tilapia farming in tropical regions. http://dx.doi.org/10.21929/abavet2023.19 e2022-32 https://www.youtube.com/watch?v=77XteiY4la4 Los casos positivos a Streptococcus en tilapia ocasionan graves pérdidas económicas, sin embargo, no hay informes sobre la prevalencia de Streptococcus en tilapia cultivada en estanque y jaula en el trópico, este es el primer informe al respecto. El objetivo fue comparar la prevalencia de Streptococcus beta hemolíticos en tilapia (Oreochromis niloticus) procedentes de cultivos en estanque y jaula, en Chiapas, México, además, evaluar la susceptibilidad hacia los antibióticos. Se recolectaron 155 peces entre 250-300 gr en 31 granjas (12 estanques y 19 jaulas). La mayor prevalencia (45.16%, P<0.05) de Streptococcus beta hemoliticos., fue en peces con manifestaciones clínicas en jaulas, comparado con peces de estanques. Se identifico principalmente a S. agalactiae y S. alactolyticus. Los signos en peces infectados por Streptococcus agalactiae fueron exoftalmia, ascitis, congestión cerebral, hemorragias y melanización. El 100% de las cepas de S. agalactiae fueron susceptibles a betalactámicos, clindamicinas, entre otros. Existe mayor prevalencia de Streptococcus spp., en los peces mantenidos en jaula comparado con el cultivo de estanque. La información generada en este estudio favorece a la implementación de estrategias sanitarias para optimizar la cría de tilapia en las regiones del trópico. http://dx.doi.org/10.21929/abavet2023.19 e2022-32 https://www.youtube.com/watch?v=77XteiY4la4 http://dx.doi.org/10.21929/abavet2023.19 e2022-32 https://www.youtube.com/watch?v=77XteiY4la4

9 November 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
PCPaola Correa
Paola Correa
JHJosé Miguel Pérez Hernandez
José Miguel Pérez Hernandez
Bernardo Alfonso Martinez-GuerraBernardo Alfonso Martinez-Guerra
Bernardo Alfonso Martinez-Guerra
EREduardo Rodriguez-Noriega
Eduardo Rodriguez-Noriega
JRJuan Pablo Mena Ramirez
Juan Pablo Mena Ramirez
Elvira Garza-GonzálezElvira Garza-González
Elvira Garza-González
The classification of carbapenemases can help guide therapy. The present study evaluated the performance of the CPO detection test, included in the BD Phoenix™ NMIC-501 panel for the detection and classification of carbapenemases on the representative molecularly characterized strains collection from Mexico. Carbapenem non-susceptible isolates collected in Mexico were included. The clinical isolates (n = 484) comprised Klebsiella pneumoniae (n = 154), Escherichia coli (n = 150), and P. aeruginosa (n = 180). BD Phoenix CPO NMIC-504 and NMIC-501 panels were used for the identification of species, antimicrobial susceptibility tests, and detection of CPOs. For the detection of carbapenemase-encoding genes, E. coli and K. pneumoniae were evaluated using PCR assays for blaNDM-1, blaKPC, blaVIM, blaIMP, and blaOXA-48-like. For P. aeruginosa, blaVIM, blaIMP, and blaGES were detected using PCR. Regarding E. coli, the CPO panels had a sensitivity of 70% and specificity of 83.33% for the detection of a class B carbapenemase (blaNDM in the molecular test). Regarding K. pneumoniae, the panels had a sensitivity of 75% and specificity of 100% for the detection of a class A carbapenemase (blaKPC in the molecular test). The Phoenix NMIC-501 panels are reliable for detecting class B carbapenemases in E. coli. The carbapenemase classification in K. pneumoniae for class A carbapenemases has a high specificity and PPV; thus, a positive result is of high value.